Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Melatonin in the Management of Mood and Sleep Problems Induced by Androgen Deprivation Therapy in Prostate Cancer Patients: A Randomized Double-Blinded, Placebo-Controlled Clinical Trial Publisher



Etedali A1 ; Hosseni AK1 ; Derakhshandeh A2 ; Mehrzad V2 ; Sharifi M2 ; Moghaddas A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Internal Medicine, Oncology and Hematology Section, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Journal of Pharmaceutical Research Published:2022


Abstract

Background: Androgen deprivation therapy (ADT) has been considered as a mainstay of treatment for advanced prostate cancer. Considering ADT for cancer patients is accompanied with many side effects, such as behavioral and neurologic side effects that adversely affect the quality of life. Objectives: This study aimed to evaluate the effects of melatonin administration on sleep problems and mood changes induced by ADT in prostate cancer patients. Methods: The randomized, double-blind, placebo-controlled trial was designed in the oncology-hematology outpatient clinic of Omid Hospital, Isfahan, Iran. After screening by the hospital anxiety and depression scale (HADS), patients were divided into either an intervention group receiving 6 mg melatonin daily for four weeks or an identical placebo. After that, patients were evaluated by the Pittsburgh sleep quality index (PSQI), the Hamilton Anxiety Rating Scale (HAM-A), and Beck Depression Inventory (BDI) questionnaires at baseline and after 4-week follow-ups. Results: Forty-three patients, including 21 and 22 patients in melatonin and placebo groups, respectively completed follow-ups period. Melatonin administration significantly improved PSQI scores in four domains of sleep quality, sleep latency, sleep efficacy, and daytime dysfunction. After 4-week melatonin supplementation, the severity of depression and anxiety assessed by BDI and HAM-A questionnaires, respectively, decreased non-statistically significant in both melatonin and placebo groups. Conclusions: In our study, melatonin supplementation ameliorated ADT-induced sleep problems in patients with prostate cancers; however, for more conclusive results, further future large and well-designed clinical studies. © 2022, Author(s).
Related Docs
View other Related Docs
1. Melatonin Aids in Treating Mood and Sleep Problems Resulting From Hormonal Therapy in Breast Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial, Iranian Journal of Pharmaceutical Research (2024)
2. Omega-3 in the Subjective Betterment of Mood and Sleep Disturbances Induced by Hormone Therapy in Women With Breast Cancer: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial, Sleep and Vigilance (2024)
3. Effects of Melatonin Supplementation on Bdnf Concentrations and Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Behavioural Brain Research (2023)
4. The Effect of Melatonin on Improving the Benign Prostatic Hyperplasia Urinary Symptoms, a Randomized Clinical Trial, Urology Journal (2022)
5. The Effect of a Bioenergy Economy-Based Program on the Wellbeing of Patients With Breast Cancer, International Journal of Body, Mind and Culture (2022)
6. Effect of Melatonin Supplementation on Oxidative Stress Parameters: A Systematic Review and Meta-Analysis, Pharmacological Research (2020)
7. Effects of Melatonin Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Hormone and Metabolic Research (2019)
8. Melatonin As a Regulator of Apoptosis in Leukaemia: Molecular Mechanism and Therapeutic Perspectives, Frontiers in Pharmacology (2023)
Experts (# of related papers)
View all Related Experts
Mehran Sharifi (4)
Azadeh Moghaddas (3)
Other Related Docs
9. Effect of Melatonin Supplementation on Sleep Quality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Journal of Neurology (2022)
10. Risk of Depression After Parkinson's Disease, Stroke, Multiple Sclerosis, and Migraine in an Iranian Population and Assess Psychometric Characteristics of Three Prevalent Depression Questionnaires, IBRO Neuroscience Reports (2024)
11. Morning and Nocturnal Serum Melatonin Rhythm Levels in Patients With Major Depressive Disorder: An Analytical Cross-Sectional Study; [Medir Los Niveles Del Ritmo De Melatonina Dia-Noche Entre Los Pacientes Con Trastorno Depresivo Mayor: Un Estudio Analitico Transversal], Sao Paulo Medical Journal (2012)
12. Comparison of the Effect of Escitalopram and Placebo on Quality of Life and Depressive Symptoms in Patients With Breast Cancer and Mastectomy, Journal of Isfahan Medical School (2018)
13. Melatonin and Non-Small Cell Lung Cancer: New Insights Into Signaling Pathways, Cancer Cell International (2019)
14. Influence of Adjuvant Omega-3-Polyunsaturated Fatty Acids on Depression, Sleep, and Emotion Regulation Among Outpatients With Major Depressive Disorders - Results From a Double-Blind, Randomized and Placebo-Controlled Clinical Trial, Journal of Psychiatric Research (2018)
15. The Mediating Roles of Anxiety, Depression, Sleepiness, Insomnia, and Sleep Quality in the Association Between Problematic Social Media Use and Quality of Life Among Patients With Cancer, Healthcare (Switzerland) (2022)
16. Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: A Double-Blind, Placebo-Controlled Study, Asian Pacific Journal of Cancer Prevention (2018)
17. Effect of Omega-3 Fatty Acid Supplements on Cancer-Related Fatigue in an Outpatient Setting: A Randomized Controlled Trial, Middle East Journal of Cancer (2019)
18. Effect of Melatonin Supplementation on Body Composition and Blood Pressure in Adults: A Systematic Review and Dose–Response Meta-Analysis of Randomized Controlled Trial, Heliyon (2024)
19. Evaluation of Sleep Training Effectiveness on the Quality of Sleep in Cancer Patients During Chemotherapy, Advanced Biomedical Research (2021)
20. Melatonin As a Promising Agent for Cancer Treatment: Insights Into Its Effects on the Wnt/Beta-Catenin Signaling Pathway, Current Medicinal Chemistry (2024)
21. Melatonin Supplementation Improves N-Terminal Pro-B-Type Natriuretic Peptide Levels and Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Results From Mehr Trial, a Randomized Clinical Trial, Clinical Cardiology (2022)
22. Effectiveness of Schema Therapy on Anxiety, Depression, Fatigue, Quality of Life, and Sleep in Patients With Multiple Sclerosis: A Randomized Controlled Trial, Middle East Journal of Rehabilitation and Health Studies (2024)
23. Melatonin in the Prevention of Cisplatin-Induced Acute Nephrotoxicity: A Randomized, Controlled Clinical Trial, Research in Pharmaceutical Sciences (2022)
24. Relationship of Ambivalence Over Emotional Expression and Cancer-Related Fatigue With Adherence to Treatment in Patients With Cancer, International Journal of Body, Mind and Culture (2024)
25. Comparing the Effect of Emotional Freedom Technique on Sleep Quality and Happiness of Women Undergoing Breast Cancer Surgery in Military and Nonmilitary Families: A Quasi-Experimental Multicenter Study, Perspectives in Psychiatric Care (2022)
26. The Effects of Alcoholic Extract of Saffron (Crocus Satious L.) on Mild to Moderate Comorbid Depression-Anxiety, Sleep Quality, and Life Satisfaction in Type 2 Diabetes Mellitus: A Double-Blind, Randomized and Placebo-Controlled Clinical Trial, Complementary Therapies in Medicine (2018)
27. Impact of Melatonin Supplementation on Glycemic Parameters in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis, Current Pharmaceutical Design (2025)